Takeda Oncology
Jennifer Thompson Giezek has over a decade of experience in program management and global medical affairs, currently serving as Head of the Program Management Office at Takeda Oncology since June 2011. Previously, Giezek held leadership roles in program management and operations within the oncology business unit and was instrumental in overseeing oncology business development and pipeline program management. Prior to Takeda, Giezek gained valuable experience at Adante Staffing, where responsibilities included recruiting and operations management, and served as a College Recruiting & Human Resources Intern at The May Institute. Giezek holds a Bachelor’s degree in International Studies and Political Science from Stonehill College and is a certified Project Management Professional (PMP).
This person is not in any teams
This person is not in any offices
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.